Σύνδρομο Στίβενς-Τζόνσον (Greek Wikipedia)

Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.». Journal of the American Academy of Dermatology 69 (2): 173.e1–13; quiz 185–6. doi:10.1016/j.jaad.2013.05.003. PMID 23866878.
«Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology 177 (5): 1234–1247. 2017. doi:10.1111/bjd.15423. PMID 28256714.
«Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis». Clinical Reviews in Allergy & Immunology 54 (1): 147–176. 2017. doi:10.1007/s12016-017-8654-z. PMID 29188475.
Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer και άλλοι. (2017). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines» (στα αγγλικά). JAMA Dermatology 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. PMID 28296986. Αρχειοθετήθηκε από το πρωτότυπο στις 2019-12-03. https://web.archive.org/web/20191203081548/https://www.zora.uzh.ch/id/eprint/144140/1/LF_2017_Stevens-Johnson_Syndrome_and_Toxic_Necrolysis_Standard_Reporting_and_Evaluation_Guidlines_-_Results_of_a_National_Institutes_of_Health_Working_Group.pdf. Ανακτήθηκε στις 2022-11-27.
«Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist». Current Rheumatology Reports 19 (1): 3. January 2017. doi:10.1007/s11926-017-0626-z. PMID 28138822.
Tan SK, Tay YK; Tay (2012). «Profile and pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a general hospital in Singapore: Treatment outcomes». Acta Dermato-Venereologica 92 (1): 62–6. doi:10.2340/00015555-1169. PMID 21710108.
Mockenhaupt M (2011). «The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis». Expert Review of Clinical Immunology 7 (6): 803–15. doi:10.1586/eci.11.66. PMID 22014021.
Teraki Y, Shibuya M, Izaki S; Shibuya; Izaki (2010). «Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations». Clin. Exp. Dermatol. 35 (7): 723–8. doi:10.1111/j.1365-2230.2009.03718.x. PMID 19874350.
Cooper KL (2012). «Drug reaction, skin care, skin loss». Crit Care Nurse 32 (4): 52–9. doi:10.4037/ccn2012340. PMID 22855079. https://archive.org/details/sim_critical-care-nurse_2012-08_32_4/page/52.
Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H; Haddad; Mockenhaupt; Dunant; Liss; Bork; Haustein; Vieluf και άλλοι. (2010). «ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Comparison with case-control analysis». Clinical Pharmacology & Therapeutics 88 (1): 60–8. doi:10.1038/clpt.2009.252. PMID 20375998. https://semanticscholar.org/paper/c4eadf168aee2afb5e2a14a46068b26384ba3fc3.
Raksha MP, Marfatia YS; Marfatia (2008). «Clinical study of cutaneous drug eruptions in 200 patients». Indian Journal of Dermatology, Venereology and Leprology 74 (1): 80. doi:10.4103/0378-6323.38431. PMID 18193504. http://www.bioline.org.br/pdf?dv08031.
Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; Mockenhaupt; Bouwes-Bavinck; Naldi; Viboud; Roujeau; Euroscar Study (2001). «Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis». AIDS 15 (14): 1843–8. doi:10.1097/00002030-200109280-00014. PMID 11579247.
Devi K, George S, Criton S, Suja V, Sridevi PK; George; Criton; Suja; Sridevi (2005). «Carbamazepine – The commonest cause of toxic epidermal necrolysis and Stevens–Johnson syndrome: A study of 7 years». Indian Journal of Dermatology, Venereology and Leprology 71 (5): 325–8. doi:10.4103/0378-6323.16782. PMID 16394456.
«Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid». Am J Clin Dermatol 8 (2): 107–11. 2007. doi:10.2165/00128071-200708020-00007. PMID 17428116.
Ward KE, Archambault R, Mersfelder TL; Archambault; Mersfelder (2010). «Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature». American Journal of Health-System Pharmacy 67 (3): 206–213. doi:10.2146/ajhp080603. PMID 20101062.
Trujillo C, Gago C, Ramos S; Gago; Ramos (2010). «Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient». Allergol Immunopathol (Madr) 38 (2): 99–100. doi:10.1016/j.aller.2009.06.009. PMID 19875224.
«Adverse cutaneous drug eruptions: current understanding». Seminars in Immunopathology 38 (1): 75–86. January 2016. doi:10.1007/s00281-015-0540-2. PMID 26553194.
«Chapter 28: Classification of hypersensitivity reactions». Allergy and Asthma Proceedings 33 Suppl 1 (3): S96–9. 2012. doi:10.2500/aap.2012.33.3561. PMID 22794701.
«Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy». International Journal of Molecular Sciences 17 (8): 1214. 2016. doi:10.3390/ijms17081214. PMID 27472323.
«Severe cutaneous adverse reactions to drugs». Lancet 390 (10106): 1996–2011. 2017. doi:10.1016/S0140-6736(16)30378-6. PMID 28476287.
«Pustular psoriasis and related pustular skin diseases». The British Journal of Dermatology 178 (3): 614–618. January 2018. doi:10.1111/bjd.16232. PMID 29333670.
«Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms». International Archives of Allergy and Immunology 171 (3–4): 166–179. 2016. doi:10.1159/000453265. PMID 27960170.
«Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions». Current Opinion in Allergy and Clinical Immunology 16 (4): 339–45. 2016. doi:10.1097/ACI.0000000000000286. PMID 27362322.
«HLA Association with Drug-Induced Adverse Reactions». Journal of Immunology Research 2017: 3186328. 2017. doi:10.1155/2017/3186328. PMID 29333460.
«Pharmacogenomics of off-target adverse drug reactions». British Journal of Clinical Pharmacology 83 (9): 1896–1911. September 2017. doi:10.1111/bcp.13294. PMID 28345177.
«Genomics of Adverse Drug Reactions». Trends in Pharmacological Sciences 38 (1): 100–109. January 2017. doi:10.1016/j.tips.2016.11.003. PMID 27955861.
«Genetic variants associated with phenytoin-related severe cutaneous adverse reactions». JAMA 312 (5): 525–34. August 2014. doi:10.1001/jama.2014.7859. PMID 25096692. https://archive.org/details/sim_jama_2014-08-06_312_5/page/n69.
«Severe cutaneous adverse drug reactions». The Journal of Dermatology 43 (7): 758–66. 2016. doi:10.1111/1346-8138.13430. PMID 27154258.
Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; Mockenhaupt; Naldi; Correia; Schröder; Roujeau; SCAR Study Group. Severe Cutaneous Adverse Reactions (2002). «Correlations between clinical patterns and causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis results of an international prospective study». Archives of Dermatology 138 (8): 1019–24. doi:10.1001/archderm.138.8.1019. PMID 12164739. https://archive.org/details/sim_jama-dermatology_2002-08_138_8/page/1019.
Stevens, A.M.; Johnson, F.C. (1922). «A new eruptive fever associated with stomatitis and ophthalmia; Report of two cases in children». American Journal of Diseases of Children 24 (6): 526–33. doi:10.1001/archpedi.1922.04120120077005. Αρχειοθετήθηκε από το πρωτότυπο στις 3 January 2014. https://web.archive.org/web/20140103023904/http://books.google.com/books?id=E90fAAAAIAAJ&pg=PA526.

europa.eu (Global: 68^th place; Greek: 24^th place)

ema.europa.eu

«Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)» (PDF) (data sheet). European Medicines Agency. 6 Απριλίου 2017.

fda.gov (Global: 447^th place; Greek: 368^th place)

fda.gov

«Provigil (modafinil) Tablets». MedWatch. US Food and Drug Administration. 24 Οκτωβρίου 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Δεκεμβρίου 2013.

accessdata.fda.gov

«Incivek prescribing information» (PDF) (package insert). Vertex Pharmaceuticals. Δεκεμβρίου 2012. Αρχειοθετήθηκε (PDF) από το πρωτότυπο στις 15 Μαρτίου 2013.

jpma.org.pk (Global: low place; Greek: low place)

Khawaja A, Shahab A, Hussain SA; Shahab; Hussain (2012). «Acetaminophen induced Steven Johnson syndrome-Toxic Epidermal Necrolysis overlap». Journal of Pakistan Medical Association 62 (5): 524–7. PMID 22755330. Αρχειοθετήθηκε από το πρωτότυπο στις 30 December 2014. https://web.archive.org/web/20141230130734/http://www.jpma.org.pk/full_article_text.php?article_id=3419.

medsafe.govt.nz (Global: low place; Greek: low place)

«Diflucan One» (data sheet). Medsafe; New Zealand Ministry of Health. 29 Απριλίου 2008. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Ιουνίου 2010.

medscape.com (Global: 719^th place; Greek: 579^th place)

emedicine.medscape.com

Foster, C. StephenΣφάλμα έκφρασης: Μη αναγνωρισμένη λέξη "etal" (12 August 2013). Roy, Hampton Sr. (article editor). «Stevens-Johnson Syndrome». Medscape Reference: Etiology. Αρχειοθετήθηκε από το πρωτότυπο στις 22 January 2013. https://web.archive.org/web/20130122091022/http://emedicine.medscape.com/article/1197450-overview#aw2aab6b2b3.

nih.gov (Global: 4^th place; Greek: 4^th place)

ncbi.nlm.nih.gov

Schwartz, RA; McDonough, PH; Lee, BW (August 2013). «Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.». Journal of the American Academy of Dermatology 69 (2): 173.e1–13; quiz 185–6. doi:10.1016/j.jaad.2013.05.003. PMID 23866878.
«Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology 177 (5): 1234–1247. 2017. doi:10.1111/bjd.15423. PMID 28256714.
«Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis». Clinical Reviews in Allergy & Immunology 54 (1): 147–176. 2017. doi:10.1007/s12016-017-8654-z. PMID 29188475.
Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer και άλλοι. (2017). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines» (στα αγγλικά). JAMA Dermatology 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. PMID 28296986. Αρχειοθετήθηκε από το πρωτότυπο στις 2019-12-03. https://web.archive.org/web/20191203081548/https://www.zora.uzh.ch/id/eprint/144140/1/LF_2017_Stevens-Johnson_Syndrome_and_Toxic_Necrolysis_Standard_Reporting_and_Evaluation_Guidlines_-_Results_of_a_National_Institutes_of_Health_Working_Group.pdf. Ανακτήθηκε στις 2022-11-27.
«Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist». Current Rheumatology Reports 19 (1): 3. January 2017. doi:10.1007/s11926-017-0626-z. PMID 28138822.
Tan SK, Tay YK; Tay (2012). «Profile and pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a general hospital in Singapore: Treatment outcomes». Acta Dermato-Venereologica 92 (1): 62–6. doi:10.2340/00015555-1169. PMID 21710108.
Mockenhaupt M (2011). «The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis». Expert Review of Clinical Immunology 7 (6): 803–15. doi:10.1586/eci.11.66. PMID 22014021.
Teraki Y, Shibuya M, Izaki S; Shibuya; Izaki (2010). «Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations». Clin. Exp. Dermatol. 35 (7): 723–8. doi:10.1111/j.1365-2230.2009.03718.x. PMID 19874350.
Cooper KL (2012). «Drug reaction, skin care, skin loss». Crit Care Nurse 32 (4): 52–9. doi:10.4037/ccn2012340. PMID 22855079. https://archive.org/details/sim_critical-care-nurse_2012-08_32_4/page/52.
Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H; Haddad; Mockenhaupt; Dunant; Liss; Bork; Haustein; Vieluf και άλλοι. (2010). «ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Comparison with case-control analysis». Clinical Pharmacology & Therapeutics 88 (1): 60–8. doi:10.1038/clpt.2009.252. PMID 20375998. https://semanticscholar.org/paper/c4eadf168aee2afb5e2a14a46068b26384ba3fc3.
Raksha MP, Marfatia YS; Marfatia (2008). «Clinical study of cutaneous drug eruptions in 200 patients». Indian Journal of Dermatology, Venereology and Leprology 74 (1): 80. doi:10.4103/0378-6323.38431. PMID 18193504. http://www.bioline.org.br/pdf?dv08031.
Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; Mockenhaupt; Bouwes-Bavinck; Naldi; Viboud; Roujeau; Euroscar Study (2001). «Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis». AIDS 15 (14): 1843–8. doi:10.1097/00002030-200109280-00014. PMID 11579247.
Devi K, George S, Criton S, Suja V, Sridevi PK; George; Criton; Suja; Sridevi (2005). «Carbamazepine – The commonest cause of toxic epidermal necrolysis and Stevens–Johnson syndrome: A study of 7 years». Indian Journal of Dermatology, Venereology and Leprology 71 (5): 325–8. doi:10.4103/0378-6323.16782. PMID 16394456.
«Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid». Am J Clin Dermatol 8 (2): 107–11. 2007. doi:10.2165/00128071-200708020-00007. PMID 17428116.
Ward KE, Archambault R, Mersfelder TL; Archambault; Mersfelder (2010). «Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature». American Journal of Health-System Pharmacy 67 (3): 206–213. doi:10.2146/ajhp080603. PMID 20101062.
Khawaja A, Shahab A, Hussain SA; Shahab; Hussain (2012). «Acetaminophen induced Steven Johnson syndrome-Toxic Epidermal Necrolysis overlap». Journal of Pakistan Medical Association 62 (5): 524–7. PMID 22755330. Αρχειοθετήθηκε από το πρωτότυπο στις 30 December 2014. https://web.archive.org/web/20141230130734/http://www.jpma.org.pk/full_article_text.php?article_id=3419.
Trujillo C, Gago C, Ramos S; Gago; Ramos (2010). «Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient». Allergol Immunopathol (Madr) 38 (2): 99–100. doi:10.1016/j.aller.2009.06.009. PMID 19875224.
«Adverse cutaneous drug eruptions: current understanding». Seminars in Immunopathology 38 (1): 75–86. January 2016. doi:10.1007/s00281-015-0540-2. PMID 26553194.
«Chapter 28: Classification of hypersensitivity reactions». Allergy and Asthma Proceedings 33 Suppl 1 (3): S96–9. 2012. doi:10.2500/aap.2012.33.3561. PMID 22794701.
«Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy». International Journal of Molecular Sciences 17 (8): 1214. 2016. doi:10.3390/ijms17081214. PMID 27472323.
«Severe cutaneous adverse reactions to drugs». Lancet 390 (10106): 1996–2011. 2017. doi:10.1016/S0140-6736(16)30378-6. PMID 28476287.
«Pustular psoriasis and related pustular skin diseases». The British Journal of Dermatology 178 (3): 614–618. January 2018. doi:10.1111/bjd.16232. PMID 29333670.
«Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms». International Archives of Allergy and Immunology 171 (3–4): 166–179. 2016. doi:10.1159/000453265. PMID 27960170.
«Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions». Current Opinion in Allergy and Clinical Immunology 16 (4): 339–45. 2016. doi:10.1097/ACI.0000000000000286. PMID 27362322.
«HLA Association with Drug-Induced Adverse Reactions». Journal of Immunology Research 2017: 3186328. 2017. doi:10.1155/2017/3186328. PMID 29333460.
«Pharmacogenomics of off-target adverse drug reactions». British Journal of Clinical Pharmacology 83 (9): 1896–1911. September 2017. doi:10.1111/bcp.13294. PMID 28345177.
«Genomics of Adverse Drug Reactions». Trends in Pharmacological Sciences 38 (1): 100–109. January 2017. doi:10.1016/j.tips.2016.11.003. PMID 27955861.
snpdev. «Reference SNP (refSNP) Cluster Report: rs1057910 ** With drug-response allele **». www.ncbi.nlm.nih.gov.
«Genetic variants associated with phenytoin-related severe cutaneous adverse reactions». JAMA 312 (5): 525–34. August 2014. doi:10.1001/jama.2014.7859. PMID 25096692. https://archive.org/details/sim_jama_2014-08-06_312_5/page/n69.
«Severe cutaneous adverse drug reactions». The Journal of Dermatology 43 (7): 758–66. 2016. doi:10.1111/1346-8138.13430. PMID 27154258.
Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; Mockenhaupt; Naldi; Correia; Schröder; Roujeau; SCAR Study Group. Severe Cutaneous Adverse Reactions (2002). «Correlations between clinical patterns and causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis results of an international prospective study». Archives of Dermatology 138 (8): 1019–24. doi:10.1001/archderm.138.8.1019. PMID 12164739. https://archive.org/details/sim_jama-dermatology_2002-08_138_8/page/1019.

pubmedcentral.nih.gov

«Recent advances in the understanding of severe cutaneous adverse reactions». The British Journal of Dermatology 177 (5): 1234–1247. 2017. doi:10.1111/bjd.15423. PMID 28256714.
«Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy». International Journal of Molecular Sciences 17 (8): 1214. 2016. doi:10.3390/ijms17081214. PMID 27472323.
«HLA Association with Drug-Induced Adverse Reactions». Journal of Immunology Research 2017: 3186328. 2017. doi:10.1155/2017/3186328. PMID 29333460.
«Pharmacogenomics of off-target adverse drug reactions». British Journal of Clinical Pharmacology 83 (9): 1896–1911. September 2017. doi:10.1111/bcp.13294. PMID 28345177.

ghr.nlm.nih.gov

«Stevens-Johnson syndrome/toxic epidermal necrolysis». Genetics Home Reference (στα Αγγλικά). Ιουλίου 2015. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Απριλίου 2017. Ανακτήθηκε στις 26 Απριλίου 2017.

rarediseases.info.nih.gov

«Stevens-Johnson syndrome». GARD. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2016. Ανακτήθηκε στις 26 Αυγούστου 2016.

orpha.net (Global: 3,537^th place; Greek: 2,148^th place)

«Orphanet: Toxic epidermal necrolysis». Orphanet (στα Αγγλικά). Νοεμβρίου 2008. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Απριλίου 2017. Ανακτήθηκε στις 26 Απριλίου 2017.

pediatricsconsultantlive.com (Global: low place; Greek: low place)

Tigchelaar, H.· Kannikeswaran, N.· Kamat, D. (Δεκεμβρίου 2008). «Stevens–Johnson Syndrome: An intriguing diagnosis». pediatricsconsultantlive.com. UBM Medica. Αρχειοθετήθηκε από το πρωτότυπο στις 17 Αυγούστου 2012.

pharmaceutical-journal.com (Global: low place; Greek: 9,442^nd place)

Bentley, John; Sie, David (8 October 2014). «Stevens-Johnson syndrome and toxic epidermal necrolysis». The Pharmaceutical Journal 293 (7832). Αρχειοθετήθηκε από το πρωτότυπο στις 12 October 2014. https://web.archive.org/web/20141012190345/http://www.pharmaceutical-journal.com/learning/cpd-article/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis/20066728.cpdarticle. Ανακτήθηκε στις 8 October 2014.

semanticscholar.org (Global: 11^th place; Greek: 576^th place)

Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H; Haddad; Mockenhaupt; Dunant; Liss; Bork; Haustein; Vieluf και άλλοι. (2010). «ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Comparison with case-control analysis». Clinical Pharmacology & Therapeutics 88 (1): 60–8. doi:10.1038/clpt.2009.252. PMID 20375998. https://semanticscholar.org/paper/c4eadf168aee2afb5e2a14a46068b26384ba3fc3.

uzh.ch (Global: 3,633^rd place; Greek: 3,413^th place)

zora.uzh.ch

Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer και άλλοι. (2017). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines» (στα αγγλικά). JAMA Dermatology 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. PMID 28296986. Αρχειοθετήθηκε από το πρωτότυπο στις 2019-12-03. https://web.archive.org/web/20191203081548/https://www.zora.uzh.ch/id/eprint/144140/1/LF_2017_Stevens-Johnson_Syndrome_and_Toxic_Necrolysis_Standard_Reporting_and_Evaluation_Guidlines_-_Results_of_a_National_Institutes_of_Health_Working_Group.pdf. Ανακτήθηκε στις 2022-11-27.

web.archive.org (Global: 1^st place; Greek: 1^st place)

«Stevens-Johnson syndrome/toxic epidermal necrolysis». Genetics Home Reference (στα Αγγλικά). Ιουλίου 2015. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Απριλίου 2017. Ανακτήθηκε στις 26 Απριλίου 2017.
«Orphanet: Toxic epidermal necrolysis». Orphanet (στα Αγγλικά). Νοεμβρίου 2008. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Απριλίου 2017. Ανακτήθηκε στις 26 Απριλίου 2017.
«Stevens-Johnson syndrome». GARD. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2016. Ανακτήθηκε στις 26 Αυγούστου 2016.
Maverakis, Emanual; Wang, Elizabeth A.; Shinkai, Kanade; Mahasirimongkol, Surakameth; Margolis, David J.; Avigan, Mark; Chung, Wen-Hung; Goldman, Jennifer και άλλοι. (2017). «Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines» (στα αγγλικά). JAMA Dermatology 153 (6): 587–592. doi:10.1001/jamadermatol.2017.0160. PMID 28296986. Αρχειοθετήθηκε από το πρωτότυπο στις 2019-12-03. https://web.archive.org/web/20191203081548/https://www.zora.uzh.ch/id/eprint/144140/1/LF_2017_Stevens-Johnson_Syndrome_and_Toxic_Necrolysis_Standard_Reporting_and_Evaluation_Guidlines_-_Results_of_a_National_Institutes_of_Health_Working_Group.pdf. Ανακτήθηκε στις 2022-11-27.
Tigchelaar, H.· Kannikeswaran, N.· Kamat, D. (Δεκεμβρίου 2008). «Stevens–Johnson Syndrome: An intriguing diagnosis». pediatricsconsultantlive.com. UBM Medica. Αρχειοθετήθηκε από το πρωτότυπο στις 17 Αυγούστου 2012.
Foster, C. StephenΣφάλμα έκφρασης: Μη αναγνωρισμένη λέξη "etal" (12 August 2013). Roy, Hampton Sr. (article editor). «Stevens-Johnson Syndrome». Medscape Reference: Etiology. Αρχειοθετήθηκε από το πρωτότυπο στις 22 January 2013. https://web.archive.org/web/20130122091022/http://emedicine.medscape.com/article/1197450-overview#aw2aab6b2b3.
«Diflucan One» (data sheet). Medsafe; New Zealand Ministry of Health. 29 Απριλίου 2008. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Ιουνίου 2010.
«Provigil (modafinil) Tablets». MedWatch. US Food and Drug Administration. 24 Οκτωβρίου 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Δεκεμβρίου 2013.
«Incivek prescribing information» (PDF) (package insert). Vertex Pharmaceuticals. Δεκεμβρίου 2012. Αρχειοθετήθηκε (PDF) από το πρωτότυπο στις 15 Μαρτίου 2013.
Khawaja A, Shahab A, Hussain SA; Shahab; Hussain (2012). «Acetaminophen induced Steven Johnson syndrome-Toxic Epidermal Necrolysis overlap». Journal of Pakistan Medical Association 62 (5): 524–7. PMID 22755330. Αρχειοθετήθηκε από το πρωτότυπο στις 30 December 2014. https://web.archive.org/web/20141230130734/http://www.jpma.org.pk/full_article_text.php?article_id=3419.
Bentley, John; Sie, David (8 October 2014). «Stevens-Johnson syndrome and toxic epidermal necrolysis». The Pharmaceutical Journal 293 (7832). Αρχειοθετήθηκε από το πρωτότυπο στις 12 October 2014. https://web.archive.org/web/20141012190345/http://www.pharmaceutical-journal.com/learning/cpd-article/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis/20066728.cpdarticle. Ανακτήθηκε στις 8 October 2014.
Stevens, A.M.; Johnson, F.C. (1922). «A new eruptive fever associated with stomatitis and ophthalmia; Report of two cases in children». American Journal of Diseases of Children 24 (6): 526–33. doi:10.1001/archpedi.1922.04120120077005. Αρχειοθετήθηκε από το πρωτότυπο στις 3 January 2014. https://web.archive.org/web/20140103023904/http://books.google.com/books?id=E90fAAAAIAAJ&pg=PA526.

whonamedit.com (Global: 2,888^th place; Greek: 3,435^th place)

Enerson, Ole Daniel, επιμ.., «Stevens-Johnson syndrome», Whonamedit?, http://www.whonamedit.com/synd.cfm/1501.html

Σύνδρομο Στίβενς-Τζόνσον (Greek Wikipedia)

archive.org (Global: 6th place; Greek: 5th place)

bioline.org.br (Global: low place; Greek: low place)

books.google.com (Global: 3rd place; Greek: 6th place)

doi.org (Global: 2nd place; Greek: 3rd place)

dx.doi.org

europa.eu (Global: 68th place; Greek: 24th place)

ema.europa.eu

fda.gov (Global: 447th place; Greek: 368th place)

fda.gov

accessdata.fda.gov

jpma.org.pk (Global: low place; Greek: low place)

medsafe.govt.nz (Global: low place; Greek: low place)

medscape.com (Global: 719th place; Greek: 579th place)

emedicine.medscape.com

nih.gov (Global: 4th place; Greek: 4th place)

ncbi.nlm.nih.gov

pubmedcentral.nih.gov

ghr.nlm.nih.gov

rarediseases.info.nih.gov

orpha.net (Global: 3,537th place; Greek: 2,148th place)

pediatricsconsultantlive.com (Global: low place; Greek: low place)

pharmaceutical-journal.com (Global: low place; Greek: 9,442nd place)

semanticscholar.org (Global: 11th place; Greek: 576th place)

uzh.ch (Global: 3,633rd place; Greek: 3,413th place)

zora.uzh.ch

web.archive.org (Global: 1st place; Greek: 1st place)

whonamedit.com (Global: 2,888th place; Greek: 3,435th place)

archive.org (Global: 6^th place; Greek: 5^th place)

books.google.com (Global: 3^rd place; Greek: 6^th place)

doi.org (Global: 2^nd place; Greek: 3^rd place)

europa.eu (Global: 68^th place; Greek: 24^th place)

fda.gov (Global: 447^th place; Greek: 368^th place)

medscape.com (Global: 719^th place; Greek: 579^th place)

nih.gov (Global: 4^th place; Greek: 4^th place)

orpha.net (Global: 3,537^th place; Greek: 2,148^th place)

pharmaceutical-journal.com (Global: low place; Greek: 9,442^nd place)

semanticscholar.org (Global: 11^th place; Greek: 576^th place)

uzh.ch (Global: 3,633^rd place; Greek: 3,413^th place)

web.archive.org (Global: 1^st place; Greek: 1^st place)

whonamedit.com (Global: 2,888^th place; Greek: 3,435^th place)